JP2003517300A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003517300A5 JP2003517300A5 JP2001535383A JP2001535383A JP2003517300A5 JP 2003517300 A5 JP2003517300 A5 JP 2003517300A5 JP 2001535383 A JP2001535383 A JP 2001535383A JP 2001535383 A JP2001535383 A JP 2001535383A JP 2003517300 A5 JP2003517300 A5 JP 2003517300A5
- Authority
- JP
- Japan
- Prior art keywords
- domain
- proline
- capsomer
- phage
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000126 substance Substances 0.000 description 20
- 238000000034 method Methods 0.000 description 17
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 12
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 12
- 108090000623 proteins and genes Proteins 0.000 description 9
- 102000004169 proteins and genes Human genes 0.000 description 9
- 108090000765 processed proteins & peptides Proteins 0.000 description 7
- 235000018102 proteins Nutrition 0.000 description 7
- 241000700605 Viruses Species 0.000 description 5
- 210000000234 capsid Anatomy 0.000 description 4
- 230000003612 virological effect Effects 0.000 description 4
- 235000018417 cysteine Nutrition 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 150000001945 cysteines Chemical class 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 102000053642 Catalytic RNA Human genes 0.000 description 1
- 108090000994 Catalytic RNA Proteins 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 102000007079 Peptide Fragments Human genes 0.000 description 1
- 108010033276 Peptide Fragments Proteins 0.000 description 1
- 108091093037 Peptide nucleic acid Proteins 0.000 description 1
- 102000016611 Proteoglycans Human genes 0.000 description 1
- 108010067787 Proteoglycans Proteins 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical group 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 102000034356 gene-regulatory proteins Human genes 0.000 description 1
- 108091006104 gene-regulatory proteins Proteins 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 125000003473 lipid group Chemical group 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 239000003910 polypeptide antibiotic agent Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 108091092562 ribozyme Proteins 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19952956A DE19952956A1 (de) | 1999-11-03 | 1999-11-03 | Verfahren zur Verbindung von molekularen Substanzen |
| DE19952956.6 | 1999-11-03 | ||
| PCT/EP2000/010873 WO2001032684A2 (de) | 1999-11-03 | 2000-11-03 | Verfahren zur verbindung von molekularen substanzen basierend auf der affinität der prolinreichen aminosäure-sequenzen und proteindomänem vom typ ww |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2003517300A JP2003517300A (ja) | 2003-05-27 |
| JP2003517300A5 true JP2003517300A5 (https=) | 2006-01-05 |
| JP4112859B2 JP4112859B2 (ja) | 2008-07-02 |
Family
ID=7927813
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001535383A Expired - Fee Related JP4112859B2 (ja) | 1999-11-03 | 2000-11-03 | 分子物質を結合させる方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7807782B2 (https=) |
| EP (1) | EP1227848B1 (https=) |
| JP (1) | JP4112859B2 (https=) |
| CN (1) | CN100357314C (https=) |
| AT (1) | ATE326984T1 (https=) |
| AU (1) | AU2154801A (https=) |
| DE (2) | DE19952956A1 (https=) |
| WO (1) | WO2001032684A2 (https=) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4885476B2 (ja) * | 2004-05-21 | 2012-02-29 | 株式会社日本触媒 | タンパク質及び／又はペプチドの細胞内導入方法 |
| CA2697032C (en) | 2007-08-22 | 2021-09-14 | The Regents Of The University Of California | Activatable binding polypeptides and methods of identification and use thereof |
| US20100189651A1 (en) * | 2009-01-12 | 2010-07-29 | Cytomx Therapeutics, Llc | Modified antibody compositions, methods of making and using thereof |
| JP5861223B2 (ja) * | 2009-02-23 | 2016-02-16 | サイトムエックス セラピューティクス, インク.CytomX Therapeutics, Inc. | プロタンパク質およびその使用方法 |
| JP6236948B2 (ja) * | 2013-07-17 | 2017-11-29 | 東ソー株式会社 | 抗体精製用溶出液および当該溶出液を用いた抗体精製方法 |
| GB201409558D0 (en) | 2014-05-29 | 2014-07-16 | Ucb Biopharma Sprl | Method |
| GB201412659D0 (en) | 2014-07-16 | 2014-08-27 | Ucb Biopharma Sprl | Molecules |
| GB201412658D0 (en) | 2014-07-16 | 2014-08-27 | Ucb Biopharma Sprl | Molecules |
| GB201601073D0 (en) | 2016-01-20 | 2016-03-02 | Ucb Biopharma Sprl | Antibodies |
| GB201601075D0 (en) | 2016-01-20 | 2016-03-02 | Ucb Biopharma Sprl | Antibodies molecules |
| GB201601077D0 (en) | 2016-01-20 | 2016-03-02 | Ucb Biopharma Sprl | Antibody molecule |
| GB201521391D0 (en) | 2015-12-03 | 2016-01-20 | Ucb Biopharma Sprl | Antibodies |
| GB201521383D0 (en) | 2015-12-03 | 2016-01-20 | Ucb Biopharma Sprl And Ucb Celltech | Method |
| GB201521389D0 (en) | 2015-12-03 | 2016-01-20 | Ucb Biopharma Sprl | Method |
| GB201521382D0 (en) | 2015-12-03 | 2016-01-20 | Ucb Biopharma Sprl | Antibodies |
| GB201521393D0 (en) | 2015-12-03 | 2016-01-20 | Ucb Biopharma Sprl | Antibodies |
| US11202841B2 (en) * | 2018-08-20 | 2021-12-21 | The Trustees Of Indiana University | Virus-enabled targeted vector for imaging |
| CN111979206B (zh) * | 2019-05-24 | 2021-08-17 | 深圳瑞德林生物技术有限公司 | 固定化融合酶及用其制备谷胱甘肽的方法 |
| CN117642413A (zh) * | 2021-08-31 | 2024-03-01 | 富士胶片株式会社 | 化合物及使用了该化合物的标记生物物质 |
| CN115951051B (zh) * | 2022-10-18 | 2024-01-12 | 北京卓诚惠生生物科技股份有限公司 | 一种高灵敏度新型冠状病毒抗原胶体金检测试剂盒及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6072039A (en) | 1991-04-19 | 2000-06-06 | Rohm And Haas Company | Hybrid polypeptide comparing a biotinylated avidin binding polypeptide fused to a polypeptide of interest |
| US6503703B1 (en) * | 1995-05-19 | 2003-01-07 | Mount Sinai School Of Medicine Of New York University | Identification and use of antiviral compounds that inhibit interaction of host cell proteins and viral proteins required for viral replication |
| US6007544A (en) * | 1996-06-14 | 1999-12-28 | Beth Israel Deaconess Medical Center | Catheter apparatus having an improved shape-memory alloy cuff and inflatable on-demand balloon for creating a bypass graft in-vivo |
| US7666221B2 (en) * | 2000-05-01 | 2010-02-23 | Endovascular Technologies, Inc. | Lock modular graft component junctions |
| US7044962B2 (en) * | 2002-06-25 | 2006-05-16 | Scimed Life Systems, Inc. | Implantable prosthesis with displaceable skirt |
-
1999
- 1999-11-03 DE DE19952956A patent/DE19952956A1/de not_active Withdrawn
-
2000
- 2000-11-03 AT AT00984960T patent/ATE326984T1/de not_active IP Right Cessation
- 2000-11-03 AU AU21548/01A patent/AU2154801A/en not_active Abandoned
- 2000-11-03 CN CNB008153167A patent/CN100357314C/zh not_active Expired - Fee Related
- 2000-11-03 JP JP2001535383A patent/JP4112859B2/ja not_active Expired - Fee Related
- 2000-11-03 EP EP00984960A patent/EP1227848B1/de not_active Expired - Lifetime
- 2000-11-03 WO PCT/EP2000/010873 patent/WO2001032684A2/de not_active Ceased
- 2000-11-03 DE DE50012831T patent/DE50012831D1/de not_active Expired - Lifetime
-
2006
- 2006-06-01 US US11/446,587 patent/US7807782B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003517300A5 (https=) | ||
| Keinänen et al. | Biosynthetic lipid‐tagging of antibodies | |
| Hölig et al. | Novel RGD lipopeptides for the targeting of liposomes to integrin-expressing endothelial and melanoma cells | |
| Ritzefeld | Sortagging: a robust and efficient chemoenzymatic ligation strategy | |
| KR100484084B1 (ko) | 키메라성 폴리펩타이드, 이의 제조 방법 및 용도 | |
| CA2468583A1 (en) | Self-assembling multimeric binding complexes derived from ab5 toxin family members | |
| Sutherland et al. | Post‐translational assembly of protein parts into complex devices by using SpyTag/SpyCatcher protein ligase | |
| JP4112859B2 (ja) | 分子物質を結合させる方法 | |
| JP2004534831A5 (https=) | ||
| RU97107477A (ru) | Материалы для получения нанометровых структур и их применение | |
| Lee et al. | Nanoglue: an alternative way to display cell-internalizing peptide at the spikes of hepatitis B virus core nanoparticles for cell-targeting delivery | |
| JP2006521088A5 (https=) | ||
| Liu et al. | Nanoparticle delivery: targeting and nonspecific binding | |
| Bastings et al. | From phage display to dendrimer display: insights into multivalent binding | |
| Appiah Kubi et al. | Designing cell-permeable macrocyclic peptides | |
| US20100190927A1 (en) | Mhc oligomers, components thereof, and methods of making the same | |
| Morii et al. | Factors governing the sequence-selective DNA binding of geometrically constrained peptide dimers | |
| Hytönen et al. | Dual‐affinity avidin molecules | |
| WO1998022140A3 (en) | Hybrid compositions for intracellular targeting | |
| CA2511830A1 (en) | Mixture of at least two fusion proteins as well as their production and use | |
| Udit et al. | Immobilization of bacteriophage Qβ on metal-derivatized surfaces via polyvalent display of hexahistidine tags | |
| JPH04504309A (ja) | 試薬 | |
| JP2002500042A5 (https=) | ||
| JP2019523782A5 (https=) | ||
| Craenmehr et al. | Employing the SpyTag-SpyCatcher Reaction for the Modification of Supramolecular Polymers with Functional Proteins |